Process design & scale-up / INTERACTIVE LESSON 34
Why a year of the weight-loss pill takes 73 times more drug than a year of the shot
A swallowed tablet gets only 1 to 2 percent of each dose into the blood. An injection gets about 89 percent, so the pill has to carry far more drug to reach about the same blood level.
CHANGE A CONDITION. SEE WHAT FOLLOWS.
Teaching modelEnlarge for bigger labels, then swipe sideways →
At 1.22 percent bioavailability the pill has to carry 25.0 mg a day to get the same 0.305 mg a day into the blood as the 2.4 mg weekly shot. Over a year that is 9.1 g by pill against 0.12 g by the 2.4 mg shot, about 73 times more. For an illustrative million patients the pill would need 9.1 tonnes a year, or 183 batches of 50 kg, against 125 kg and 3 batches for the shot.
What this model assumes
Teaching model, not dosing advice. The 2.4 mg weekly shot absorbs 2.4 mg × 0.89 ÷ 7 = 0.305 mg a day. Pill dose needed = 0.305 mg ÷ bioavailability. Pill per year = daily dose × 365. Shot per year = weekly dose × 52 (124.8 mg at 2.4 mg). Ratio = pill per year ÷ shot per year. Batches = kilograms per year ÷ 50, rounded up to whole batches. The pill dose is always sized to match the 2.4 mg shot, so the 7.2 mg option compares the same pill supply with a shot that absorbs three times more drug. Labelled tablet values are about 1 to 2 percent (0.4 to 1 percent for the earlier tablet); the slider runs from 0.4 to 5 percent. The model ignores dose titration in the first 90 days, the wider patient-to-patient spread on the pill (90 percent of patients between 27 and 186 nmol/L, against 51 and 110 nmol/L on the shot), clearance differences, manufacturing losses, the absorption enhancer mass and real plant yields. The million-patient figures multiply one patient-year by 1,000,000; they are illustrative, not a forecast.
THE IDEA TO TAKE WITH YOU
A pill that gets only 1 to 2 percent of each dose into the blood has to carry about 73 times more drug per patient-year than the weekly shot at the labelled doses.
Bioavailability is the share of a dose that reaches the blood. The weekly shot delivers about 89 percent of its dose. A swallowed tablet delivers about 1 to 2 percent, so most of each dose never gets into the blood.
To land at about the same blood level, the pill has to carry far more. The 2.4 mg weekly shot gets about 0.305 mg a day into the blood (2.4 mg × 0.89 ÷ 7). A tablet that absorbs 1.22 percent needs about 25 mg a day to match it.
Over a year, 25 mg a day adds up to about 9.1 g per patient. Fifty-two weekly doses of 2.4 mg add up to about 0.12 g, so the pill takes roughly 73 times more drug.
Against the higher labelled shot dose, 7.2 mg weekly or about 0.37 g a year, the same 25 mg pill takes about 24 times more drug.
Manufacturers who build peptides by chemistry finish batches of under about 50 kg. For an illustrative million patients, the shot would need about 125 kg a year, around three batches. The pill would need about 9 tonnes a year, more than 180 batches, before any manufacturing losses. Those million-patient figures are illustrative, not a forecast.
QUICK CHECK
If the pill's bioavailability fell to 0.5 percent, what daily dose would match the shot's absorbed dose?
FROM UNDERSTANDING TO BUILDING
Taking a real process
beyond the lab?
Jon and I are building RARE Labs toward an autonomous pilot plant builder using AI and robotics. Join the waitlist for updates, and tell us what you’re trying to scale.
FOLLOW THE EVIDENCE
Go a little deeper.
- U.S. FDA / Novo NordiskWegovy prescribing information (tablets and injection) ↗
Gives the 25 mg daily tablet, the 2.4 mg and 7.2 mg weekly injections, 89 percent bioavailability by injection, 1 to 2 percent by tablet, and the steady-state blood concentrations.
- U.S. FDA / Novo NordiskRybelsus and Ozempic tablets prescribing information ↗
Gives the oral bioavailability of the earlier and newer tablets.
- U.S. FDAClinical pharmacology review for oral semaglutide (2019) ↗
Gives the FDA's oral bioavailability estimates for the tablet.
- Journal of Organic Chemistry (Kekessie et al. 2024)Process Mass Intensity: a holistic analysis of current peptide manufacturing processes ↗
Supports the figure that chemically made peptide batches finish under about 50 kg.